Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: a Review.
Saved in:
| Title: | Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: a Review. |
|---|---|
| Authors: | Zehden JA; Department of Ophthalmology, University of North Carolina at Chapel Hill, 2226 Nelson Hwy Suite 200, Chapel Hill, NC, 27517, USA., Mortensen XM; Department of Ophthalmology, University of North Carolina at Chapel Hill, 2226 Nelson Hwy Suite 200, Chapel Hill, NC, 27517, USA., Reddy A; Athena Eye Institute, San Antonio, TX, USA.; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Zhang AY; Department of Ophthalmology, University of North Carolina at Chapel Hill, 2226 Nelson Hwy Suite 200, Chapel Hill, NC, 27517, USA. alice_zhang@med.unc.edu. |
| Source: | Current diabetes reports [Curr Diab Rep] 2022 Oct; Vol. 22 (10), pp. 525-536. Date of Electronic Publication: 2022 Sep 02. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Current Science Country of Publication: United States NLM ID: 101093791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-0829 (Electronic) Linking ISSN: 15344827 NLM ISO Abbreviation: Curr Diab Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
